18F-FCOB04
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 18F-FCOB04, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Study on the Application of ¹⁸F-FCOB04, a MAO-B Targeted PET Imaging Agent, in Neurodegenerative Diseases [EARLY_Phase 1]